China approves Pfizer Covid pill

China approves Pfizer Covid pill

Emergency authorisation the first by Beijing for a foreign coronavirus treatment

A box of Paxlovid pills for treating Covid-19 is seen at Misericordia hospital in Grosseto, Italy. (Reuters Photo)
A box of Paxlovid pills for treating Covid-19 is seen at Misericordia hospital in Grosseto, Italy. (Reuters Photo)

China has granted emergency approval for a Pfizer Covid-19 pill in a promising sign that the country could open up further to foreign vaccines and treatments for the virus.

The import registration for Paxlovid was approved on Friday, the National Medical Products Administration said in a statement on its website on Saturday. The Chinese regulator requires relevant research work to continue to be carried out, with conditional requirements completed within a time limit, and the follow-up research results submitted in a timely manner, according to the statement.

The emergency approval is the first that China has given to a drug or vaccine developed by a foreign country for Covid-19. The mRNA Covid vaccine co-developed by Pfizer and BioNTech, for which Shanghai Fosun Pharmaceutical Group holds the rights to distribute in Greater China, has not yet been approved in the country. 

China’s homegrown efforts to develop Covid antivirals have largely lagged those of the West, with the most advanced still in the final stage of trials at sites outside of the country. Such treatments could be critical to help China move away from its zero-Covid approach to managing the virus.  

After containing the virus with mass testing, surveillance and rigid border curbs, China is now uniquely vulnerable to the pathogen as it has little natural protection from prior infections. The country’s vaccination campaign has also relied on homegrown inactivated inoculations that have been less effective at blocking infections than the highly potent mRNA shots that are widely used elsewhere. 

In December, China approved a homegrown antibody therapy that needs to be administered through intravenous injections at hospitals. The two treatments co-developed by Brii Biosciences were approved for use on adults and teenage patients in mild to moderate cases.


Do you like the content of this article?
COMMENT (4)

Singapore appeals to foreign nurses but lacks residency options

Amid growing global demand for foreign nurses, Singapore has a competitive edge owing to its proximity to source countries and relatively painless application process, according to healthcare workers and experts.

30 Nov 2022

Court grants bail for 'actress-turned-scam artist' Pinky

The Criminal Court on Wednesday granted bail to actress Savika "Pinky" Chaiyadej, who has been in custody for three months pending prosecution in a huge investment scam that allegedly bilked victims of almost 2.5 billion baht.

30 Nov 2022

EU eyes special court to try Russia for Ukraine war

BRUSSELS: European Union (EU) chief Ursula von der Leyen on Wednesday floated the idea of a "specialised court" to put Russia's top officials on trial over the war in Ukraine.

30 Nov 2022